Neutrophil-Lymphocyte Ratio (NLR) Calculator
Calculates the severity of systemic inflammation by dividing absolute neutrophil count by absolute lymphocyte count.
Indications for Use
Used to stratify inflammatory and prognostic risk across conditions where elevated NLR predicts adverse outcomes. Most validated for solid tumors (high NLR consistently predicts worse overall survival across 40 559 patients 1 [Level I evidence]) and cardiovascular disease (higher quartiles predict 9–31% increased MACE risk per quartile 2 [Level I evidence]). Also supports risk assessment in acute myocarditis, with NLR ≥ 4 identifying higher mortality/transplant risk (AUC 0.72) 3 [Level II evidence].
Insights & Cautions
Interpreting NLR helps estimate inflammatory and prognostic burden, but cut‑offs vary widely across diseases. Elevated NLR predicts worse survival in solid tumors (meta‑analysis HR≈1.8 for OS 1 [Level I evidence]) and higher CV risk (20–31% increased MACE risk per quartile in multiple RCT cohorts 2 [Level I evidence]). Use cautiously—any acute infection, steroids, immune therapy, hematologic disease, or population-specific baselines can distort values 3 [Level III evidence].